Business Wire

NY-IWBI

30.11.2022 17:28:41 CET | Business Wire | Press release

Share
IWBI Launches the WELL Equity Rating to Advance Organizations and Places Where “Everyone Feels Welcome, Seen and Heard”

The International WELL Building Institute (IWBI) announced today the launch of the WELL Equity Rating, a new rating designed to help organizations act on their diversity, equity, inclusion and accessibility goals, and improve company culture and employee health. Over 30 leading organizations – including AvalonBay Communities, Canderel, Empire State Realty Trust, JLL, Overbury, Shaw Industries and the State University of New York (SUNY) College of Environmental Science and Forestry – have already enrolled in the rating, demonstrating their commitment to creating places where everyone has an equal opportunity to thrive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005749/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Graphic: Business Wire)

By providing an evidence-based roadmap, the WELL Equity Rating empowers organizations to better address the needs of marginalized and underserved populations and take an action-oriented approach to creating equitable, people-first places. The rating includes more than 40 features spanning six action areas: user experience and feedback, responsible hiring and labor practices, health benefits and services, supportive programs and spaces, and community engagement. The rating validates an organization’s actions to advance health and well-being; celebrate diversity, equity, inclusion (DEI) and accessibility; and promote sensitivity while addressing disparities in populations that have been traditionally marginalized or underserved.

“Organizations worldwide are embracing the powerful role place can play in leveling the playing field and ensuring everyone feels welcome, seen and heard,” said Rachel Hodgdon, President and CEO, IWBI. “Many organizations have made commitments to DEI, but precious few have a roadmap for activation. The WELL Equity Rating is a transformative new offering that empowers organizations to make good on their promises— with evidence-based strategies and actions that improve and strengthen company culture, advance DEI goals and address disparities in underserved populations.”

For two years, IWBI has been collaborating with its Health Equity Advisory, learning from more than 200 participating expert Advisors from 26 countries. A prestigious group of more than 40 co-chairs led the Advisory, lending their tremendous knowledge and expertise in health equity, DEI, community building and belonging, and accessible design. The development process also included feedback and input from others with lived experience who represent the target populations prioritized by the rating. These include BIPOC (Black, Indigenous and other people of color), first-generation immigrants, LGBTQ+ individuals, primary caregivers and people who are physically disabled and/or neurodivergent.

“Equity and health go hand-in-hand. This rating is all about making equitable opportunity actionable, designing healthier places that are accessible to everyone, and delivering on the promise of a global culture of health and belonging,” said Kimberly Lewis, Executive Vice President of Equity, Engagement and Events, IWBI. “Because, as we know, equity is the very foundation to healthier, stronger and thriving organizations.”

Multiple studies show that employees in diverse and inclusive workplaces are more likely to innovate, enjoy their jobs, work harder, and ultimately stay with their employers for longer. Diverse organizations have also been found to be 1.32 times more productive and 21 percent more profitable than their peers. The WELL Equity Rating offers organizations a tangible path forward to help them follow through on their DEI commitments and transform how workplaces are designed, managed and operated to create environments where everyone can thrive and show up as their authentic selves.

Coinciding with the launch, in a show of leadership, over 30 organizations representing a variety of different sectors have already enrolled to pursue the WELL Equity Rating across over 1,000 locations.

They include:

  • AHA Consulting Engineers
  • AvalonBay Communities
  • Buro Happold
  • Canderel
  • Chinachem Agencies Limited
  • Delos LLC
  • ECOS
  • Empire State Realty Trust
  • Epsten Group
  • Full Circle Design Services
  • Ivanhoé Cambridge
  • JLL
  • Landsec
  • M Moser Associates
  • Menarco Development Corporation
  • NEO
  • Neovalue
  • Overbury
  • Resilient Buildings Group
  • Shaw Industries Group, Inc.
  • Shearman and Sterling
  • Simpson Coulter Studio
  • SUNY College of Environmental Science and Forestry
  • Sustainable Investment Group LLC (SIG) - Green Building Holdings
  • The Green Engineer
  • Tuolumne County
  • Veris Residential
  • Woonerf

Equity is a core tenet of the WELL Building Standard; the majority of the features in the WELL Equity Rating were drawn from existing WELL strategies, each backed by research that demonstrates more equitable outcomes for one or more of the target populations. With the help of the Health Equity and WELL Concept Advisories, IWBI also developed new beta features and parts to strengthen the new offering. This new designation will add to the suite of IWBI offerings that includes the WELL Health-Safety Rating and the WELL Performance Rating. Each rating can be earned as a stand-alone designation or milestone toward a place-based WELL Certification or an organization’s WELL Score.

“By driving accountability and action, the WELL Equity Rating will serve as an important tool to help organizations actualize their DEI commitments, live their values and effect lasting change,” said Dr. Angelita Scott, Director and Community Concept Lead at IWBI, who also served as principal architect of the rating. “We are so grateful to all our advisors and stakeholders from around the world with different backgrounds, expertise and lived experiences who supported this effort. It’s because of their vision, input and dedication that we were able to create a third-party verified solution that will uplift historically excluded voices, enhance ESG performance and improve organizational outcomes.”

In September, IWBI’s Governance Council, the leadership body tasked with upholding the integrity of WELL through rigorous standard development criteria, unanimously ratified the WELL Equity Rating. The Governance Council is made up of distinguished global thought leaders, doctors, public health professionals and business executives, such as Dr. Richard Carmona, the 17th U.S. Surgeon General; Cheryl Durst, President and CEO of the International Interior Design Association (IIDA); Dr. Yao Wang, Director General of the International Institute of Green Finance; Alison Omens, Chief Strategy Officer at Just Capital; Mona Naqvi, Global Head of ESG and Capital Markets Strategy at S&P Global; and Nancy Roman, President and CEO of Partnership for a Healthier America.

Here’s what some early adopters are saying about the WELL Equity Rating:

"ESF's commitment to the WELL Equity Rating was a resounding ‘yes’ as we work to improve and provide equitable access to the health and well-being of our campus. The rating will guide us in acknowledging populations that have been traditionally underrepresented and promoting inclusivity while celebrating the diversity that makes this campus so vibrant and successful," said SUNY College of Environmental Science and Forestry President Joanie Mahoney. "We appreciate IWBI's work and guidance in creating this rating and continuing to lead the way in putting people first."

"At Shaw, we strive to create a better future and a better world. A world in which we collectively value and invest in the health, well-being and success of all people AND our planet. A future that's safe and safeguarded for generations to come,” said Kellie Ballew, Vice President, Global Sustainability and Innovation, Shaw Industries. “The WELL Equity Rating aligns with that commitment and stands to provide external validation of our efforts."

"Ivanhoé Cambridge is proud to be part of the early adopters of the WELL Equity Rating. As a responsible real estate leader, we look at our spaces through both the investor and the employer lenses,” said Sunita Mahant, Head of Social Impact and Inclusion, Sustainable Investment at Ivanhoé Cambridge. “Our participation solidifies our commitment to creating inclusive spaces. When people walk into our buildings, we want them to feel a sense of belonging. This starts with our own employees – which is why we are kicking off our involvement with our own headquarters in Montréal.”

"Diversity, equity and inclusion (DE&I) sheds light on the needs and priorities of underserved and underrepresented populations who are some of the most valuable members of our community,” said Raymond Rufino, CEO of NEO. “We are still at the start of our DE&I journey but welcome the roadmap that the WELL Equity Rating provides to ensure that our organizations and spaces are safe, respectful and welcoming for each and every person. We’re excited to be an early adopter of the rating and hope many other companies join the journey."

“Green Building Holdings (GBH) together with our four business units at SIG, BlueO, GBES, and Aetos are continually evaluating our DEI efforts across the greater company,” said Beka Rund, Head of People, Green Building Holdings. “We are excited to adopt the WELL Equity Rating to compliment, measure, and evaluate our company for continual improvement. It is our goal to have an inclusive culture and to lead by example for our company and the greater industry.”

“The WELL Equity program provides proven strategies to inform and validate AHA’s commitment to our employees and prospective employees,” said Adam Jennings, Director of Energy, Sustainability & Commissioning, AHA Engineers. “The effects extend well beyond AHA through our service and the services we offer our clients and community.”

About the International WELL Building Institute

The International WELL Building Institute (IWBI) is a public benefit corporation and the world’s leading organization focused on deploying people-first places to advance a global culture of health. IWBI mobilizes its community through the administration of the WELL Building Standard (WELL) and WELL ratings, management of the WELL AP credential, the pursuit of applicable research, the development of educational resources, and advocacy for policies that promote health and well-being everywhere. More information on WELL can be found here.

International WELL Building Institute pbc is a wholly owned subsidiary of Delos Living LLC. International WELL Building Institute, IWBI, the WELL Building Standard, WELL v2, WELL Certified, WELL AP, WELL Portfolio, WELL Score, The WELL Conference, We Are WELL, the WELL Community Standard, WELL Health-Safety Rating, WELL Health-Safety Rated, WELL Equity, WELL Performance Rated, WELL Performance Rating, Works with WELL, WELL and others, and their related logos are trademarks or certification marks of International WELL Building Institute pbc in the United States and other countries.

Note to Editors:

WHAT DOES HEALTH EQUITY MEAN?

Our vision aligns with the Robert Wood Johnson Foundation’s definition of health equity where “everyone has a fair and just opportunity to be as healthy as possible.” Unlike equality, which involves giving everybody the same thing, equity “recognizes that each person has different circumstances and allocates the exact resources and opportunities needed to reach an equal outcome."

We support positive and preventative health factors in the belief that health is not just the absence of disease, but intimately bound up in a person’s ability to thrive. We recognize that people benefit from this “state of balance” resulting from optimal living in mind, body and spirit, and feel “content, connected to purpose, people and community."

Fulfilling this mission means recognizing that many health disparities are rooted in systemic conditions and social determinants—including the way workplaces are designed, managed and maintained—that impose significant health burdens on certain underserved populations. RWJF’s definition sets equitable access to health as a key outcome, while diversity and inclusion are ways of achieving that goal.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005749/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye